课题基金 / 基金详情

CLOZAPINE VS HALOPERIDOL IN TREATMENT OF REFRACTORY SCHIZOPHRENIA

CLOZAPINE VS HALOPERIDOL IN TREATMENT OF REFRACTORY SCHIZOPHRENIA
氯氮平与氟哌啶醇治疗难治性精神分裂症的比较
批准号:
3901022
负责人:
L B BIGELOW
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

L B BIGELOW的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Clozapine has ben called and "atypical neuroleptic" because it does not induce the characteristic elevations in prolactin levels not does it produce the extrapyramidal reactions common to "classical" neuroleptics. We are conducting a blinded crossover study comparing clinical and biological response of treatment refractory schizophrenics to clozapine versus haloperidol. When enough patients have been studies we will have clinical, neuropsychological, and SPECT studies of each patient on haloperidol, placebo and clozapine. These results may shed some light on the underlying mechanisms for the often unique clinical responsiveness of patients to clozapine. To date four patients have begun this 18 week protocol; none have completed it.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TREATMENT OF MIGRAINE WITH ANIONIC POLYELECTROLYTES
PENTOSAN POLYSULFATE AS PROPHYLAXIS FOR MIGRAINE
CHRONIC AMPHETAMINE ADMINISTRATION IN SCHIZOPHRENIA
ANTI-HIV POTENTIAL OF PENTOSAN POLYSULFATE